Table 1.

Clinical characteristics of 31 PPGL and 12 NSCLC patients with central necrosis. SUV: standardised uptake value, MTV: metabolic tumour volume, NTF: necrotic tumour fraction, NSCLC: non-small cell lung carcinomas, PPGL: pheochromocytomas and paragangliomas.

	NSCLC (n = 12)	PPGL (n = 31)
Age (years), median (range)	65 (44–80)	62 (23–80)
Sex (M/F)	11/1	10/21
Histology	Adenocarcinoma: 4 Squamous cell carcinoma: 7 Other: 1	Pheochromocytoma: 26 Paraganglioma: 5
Noradrenergic biochemical profile (yes/no)	-	13/18
SUVmax (g/mL), median (range)	16.00 (9.05–29.77)	5.00 (2.54–36.01)
MTVvital-tumour (cm3), median (range)	36.3 (15.2–173.4)	58.3 (16.6–388.8)
MTVgross-tumour (cm3), median (range)	45.1 (18.7–327.3)	103.8 (28.7–611.2)
NTF, median (range)	0.19 (0.03–0.77)	0.23 (0.01–0.97)